The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France.
J Infect
; 81(2): 318-356, 2020 Aug.
Article
in English
| MEDLINE | ID: covidwho-141549
ABSTRACT
A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting millions of people and killing thousands. Failure to anticipate the spread of the virus now seriously threatens many health systems. We have designed a model for predicting the evolution of the SARS-CoV-2 epidemic in France, which is based on seroprevalence and makes it possible to anticipate the deconfinement strategy.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Infection Control
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
J Infect
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS